Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance
- Author(s)
- Vivien Posa, Alessia Stefanelli, Julia H. Bormio Nunes, Sonja Hager, Marlene Mathuber, Nora May, Walter Berger, Bernhard K. Keppler, Christian R. Kowol, Eva A. Enyedy, Petra Heffeter
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- University of Szeged, Medizinische Universität Wien, Universidade Estadual de Campinas, Research Cluster Translational Cancer Therapy Research, Hungarian Academy of Sciences
- Journal
- Cancers
- Volume
- 14
- No. of pages
- 27
- ISSN
- 2072-6694
- DOI
- https://doi.org/10.3390/cancers14184455
- Publication date
- 09-2022
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 301904 Cancer research
- Keywords
- ASJC Scopus subject areas
- Oncology, Cancer Research
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/3141cc0d-744d-41c2-8461-6228a5c6887f